ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, R.
Right arrow Articles by McCloskey, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, R.
Right arrow Articles by McCloskey, J
Annals of Clinical and Laboratory Science, Vol 19, Issue 5, 332-336
Copyright © 1989 by Association of Clinical Scientists


Articles

Genetic marker analysis in cases of disputed paternity when the alleged father is deceased

RA Smith, RW Gutendorf, and J McCloskey

Data are presented to demonstrate the utility of genetic marker analysis in cases of disputed paternity in which the alleged father is deceased prior to testing. The first case involves the histocompatibility (HLA) typing of the alleged father's parents and presumed mother and child, in which the deceased alleged father (AF) was not excluded from paternity. The second case involves a similar situation. However, the deceased AF was not clearly excluded from paternity in the HLA system owing to the inability to rule out gene suppression or deletion, but the deceased AF was excluded following red blood cell antigen typing of the man's parents. These two cases demonstrate the utility of genetic marker analysis in cases of disputed paternity in which the AF is deceased. This same type of analysis can be applied to cases in which the presumed mother is either deceased or missing and custody of the child is being sought by the alleged father.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the Association of Clinical Scientists.